98%
921
2 minutes
20
Objectives: Sepsis is a severe condition associated with high mortality, and hospital performance is variable. The objective of this study was to develop geospatial sepsis clusters, identify sources of variation between clusters, and test the hypothesis that redistributing sepsis patients from low-performing hospitals to higher-performing hospitals within a cluster will improve sepsis outcomes.
Design, Setting, And Patients: We conducted a cohort study of age-qualifying Medicare beneficiaries using administrative claims data from 2013 to 2015. We calculated risk-standardized mortality for hospitals then used a clustering algorithm to define geospatial cluster boundaries based on care-seeking and interhospital transfer patterns. Finally, we used simulation to model the effect of reallocating sepsis patients to higher-performing hospitals within the same cluster.
Interventions: None.
Measurements And Main Results: We included 1,125,308 patients, and they were grouped into 222 regional clusters. High-performing clusters were located largely in the Midwest, and they tended to be in less urban regions with smaller hospitals. In our simulation, the most impactful strategy was reassigning cases from the lowest-performing hospital in a cluster to the highest-performing hospital in the cluster, which was predicted to prevent 1705 deaths per year in the United States. This aggregate benefit was lower than the 5702 deaths predicted from reducing mortality by 1% absolute in hospitals in the lower half of the performance distribution.
Conclusions: Geospatial clusters provide insight into regional approaches to system-based acute care. In a simulation study, targeted sepsis regionalization appears less effective than local performance improvement in reducing preventable sepsis deaths.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12213171 | PMC |
http://dx.doi.org/10.1097/CCM.0000000000006678 | DOI Listing |
Biol Pharm Bull
September 2025
Department of Intensive Care Unit, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310007, China.
Ferroptosis is involved in the progression of sepsis-induced acute lung injury (ALI). Kaempferol is a flavonoid compound that can protect against ALI. 5-Methylcytosine (m5C) is involved in the pathogenesis of sepsis.
View Article and Find Full Text PDFMicrob Pathog
September 2025
Department of Chinese Formulae, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address:
Sepsis is a systemic inflammatory response syndrome triggered by infection. Severe sepsis is associated with dysbiosis of the intestinal flora and impaired intestinal function. Ellagic acid (EA) is a natural compound known for its ability to inhibit bacteria and viruses, thereby preventing infections.
View Article and Find Full Text PDFAm J Perinatol
September 2025
Division of Neonatology, Nemours Children's Health at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.
This study aimed to evaluate outcomes and resource utilization in neonates ≥35 weeks' gestation admitted to the neonatal intensive care unit (NICU) for persistent hypothermia, and to assess the incidence of early-onset sepsis (EOS) as well as the potential benefit of using the Kaiser Permanente EOS calculator for risk stratification.This retrospective study included 161 neonates born ≥35 weeks' gestation admitted to the NICU with persistent hypothermia (core temperature <36.5°C on three separate measurements) at a tertiary care hospital between April 2017 and June 2024.
View Article and Find Full Text PDFMol Pharm
September 2025
Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang 261053, Shandong, P. R. China.
Myocardial injury constitutes a life-threatening complication of sepsis, driven by synergistic oxidative-inflammatory pathology involving dysregulated production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and proinflammatory cytokines. This pathophysiological cascade remarkably elevates morbidity and mortality rates in septic patients, emerging as a key contributor to poor clinical outcomes. Despite its clinical significance, no clinically validated therapeutics currently exist for managing septic cardiomyopathy.
View Article and Find Full Text PDFBackgroundThis investigation aimed to determine the utility of postnatal, ultrasonographically-derived dimensions of the thymus and spleen as imaging indicators for the prediction of early-onset neonatal sepsis (EOS).Material and MethodIn this case-control study, 30 term neonates diagnosed with Early-Onset Sepsis (EOS), based on European Medicines Agency (EMA) criteria, were compared to 30 healthy, matched control neonates. All participants underwent ultrasonography to quantify thymic and splenic dimensions.
View Article and Find Full Text PDF